NO20083023L - Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur - Google Patents

Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur

Info

Publication number
NO20083023L
NO20083023L NO20083023A NO20083023A NO20083023L NO 20083023 L NO20083023 L NO 20083023L NO 20083023 A NO20083023 A NO 20083023A NO 20083023 A NO20083023 A NO 20083023A NO 20083023 L NO20083023 L NO 20083023L
Authority
NO
Norway
Prior art keywords
dendritic cells
lowered temperature
generating dendritic
generating
relates
Prior art date
Application number
NO20083023A
Other languages
English (en)
Norwegian (no)
Inventor
Alexei Kirkin
Karine Djandjougazian
Jesper Zeuthen
Original Assignee
Dandrit Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dandrit Biotech As filed Critical Dandrit Biotech As
Publication of NO20083023L publication Critical patent/NO20083023L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20083023A 2005-12-08 2008-07-08 Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur NO20083023L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501742 2005-12-08
PCT/DK2006/000694 WO2007065439A1 (en) 2005-12-08 2006-12-07 Method for generating dendritic cells employing decreased temperature

Publications (1)

Publication Number Publication Date
NO20083023L true NO20083023L (no) 2008-08-28

Family

ID=37745820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083023A NO20083023L (no) 2005-12-08 2008-07-08 Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur

Country Status (18)

Country Link
US (1) US9771558B2 (de)
EP (1) EP1971680B1 (de)
JP (1) JP2009518017A (de)
CN (1) CN101321861B (de)
AT (1) ATE545698T1 (de)
AU (1) AU2006322451A1 (de)
BR (1) BRPI0619520A2 (de)
CA (1) CA2640836C (de)
CY (1) CY1113016T1 (de)
DK (1) DK1971680T3 (de)
EA (1) EA015266B1 (de)
ES (1) ES2382565T3 (de)
IL (1) IL191782A (de)
MY (1) MY145814A (de)
NO (1) NO20083023L (de)
NZ (1) NZ569343A (de)
PT (1) PT1971680E (de)
WO (1) WO2007065439A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062502A1 (en) * 2007-11-13 2009-05-22 Dandrit Biotech A/S Method for generating tolerogenic dendritic cells employing decreased temperature
RU2486238C1 (ru) * 2011-12-29 2013-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) СПОСОБ НАГРУЗКИ ДЕНДРИТНЫХ КЛЕТОК АНТИГЕНОМ ИНФЕКЦИОННОГО ПРОИСХОЖДЕНИЯ Opisthorchis felineus
RU2663468C1 (ru) * 2017-09-25 2018-08-06 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ лечения местно-распространенного нерезектабельного рака поджелудочной железы
TW202138005A (zh) * 2019-12-27 2021-10-16 特定非營利活動法人北東日本研究機構 癌症治療方法及醫藥

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4306813B2 (ja) * 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US5849589A (en) * 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US20050084966A1 (en) * 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
AU3279301A (en) * 2000-01-11 2001-07-24 Maxygen, Inc. Monocyte-derived dendritic cell subsets
CN1168740C (zh) * 2001-04-04 2004-09-29 上海美恩生物技术有限公司 细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
US20040009596A1 (en) 2002-03-28 2004-01-15 Rao Kanury V. S. Extract from an Indian green mussel (perna viridis) for differentiation and maturation of dendric cells
JP4219789B2 (ja) * 2002-10-30 2009-02-04 独立行政法人科学技術振興機構 骨髄由来の不死化樹状細胞株
WO2004092220A1 (en) * 2003-04-14 2004-10-28 Board Of Regents, The University Of Texas System Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
US20050003533A1 (en) * 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
AU2006249640C1 (en) 2005-04-08 2016-10-13 Coimmune, Inc. Dendritic cell compositions and methods

Also Published As

Publication number Publication date
US9771558B2 (en) 2017-09-26
PT1971680E (pt) 2012-05-23
US20090196856A1 (en) 2009-08-06
CN101321861B (zh) 2012-10-24
EA200801385A1 (ru) 2008-10-30
WO2007065439A1 (en) 2007-06-14
EA015266B1 (ru) 2011-06-30
ES2382565T3 (es) 2012-06-11
NZ569343A (en) 2011-11-25
BRPI0619520A2 (pt) 2011-10-04
CA2640836C (en) 2018-05-15
EP1971680B1 (de) 2012-02-15
JP2009518017A (ja) 2009-05-07
IL191782A (en) 2012-05-31
MY145814A (en) 2012-04-30
AU2006322451A1 (en) 2007-06-14
ATE545698T1 (de) 2012-03-15
EP1971680A1 (de) 2008-09-24
IL191782A0 (en) 2008-12-29
DK1971680T3 (da) 2012-06-11
CN101321861A (zh) 2008-12-10
CA2640836A1 (en) 2007-06-14
CY1113016T1 (el) 2016-04-13

Similar Documents

Publication Publication Date Title
WO2009117344A3 (en) Non-hydroxide base and protein denaturant hair straightening composition and process
DE602005012233D1 (de) Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
NO20082466L (no) Delta-9-forlengelser og deres anvendelse ved merking av polyumettede fettsyrer
MY194500A (en) Methods and Compositions for Producing Fatty Alcohols
WO2009149956A3 (en) Fusion protein and use thereof
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
NO20081883L (no) Modulasjon av glukokortikoidreseptorekspresjon
DK1948789T3 (da) Fremgangsmåde til fremstilling af permanente, humane cellelinjer
EA200601822A1 (ru) Способы получения полиморфной формы i гидросульфата клопидогрела
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
NO20075275L (no) Nye forbindelser
PT1941027E (pt) Métodos e meios para proliferação de células estaminais e subsequente geração e expansão de células progenitoras, bem como produção de células efectoras como produtos terapêuticos clínicos
MX2009004493A (es) Metodo para modificar la arquitectura de vegetales y mejorar la biomasa de los vegetales y/o el rendimiento de sacarosa.
WO2009076655A3 (en) Synthetic enzymes derived from computational design
DK2010565T3 (da) Fremgangsmåde til produktion af rekombinant protein i CHO-celler
MX2010008045A (es) Activadores trascripcionales involucrados en la tolerancia al estres abiotico.
MX2021013223A (es) Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
IN2012DN03844A (de)
EA201170477A1 (ru) СПОСОБ СИНТЕЗА (Aib)hGLP-1(7-36)-NH
DK1794302T3 (da) Fremgangsmåde til at forøge frøvægt
IL191782A0 (en) Method for generating dendritic cells employing decreased temperature
EA200800107A1 (ru) Способ получения липида из клеток
WO2008060792A3 (en) Novel cells, compositions, and methods
DK1594970T3 (da) Fremgangsmåde til generering af rekombinant MVA
MY154051A (en) Management method for wax fraction storage tank

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application